Follow
Freddie Hamdy
Freddie Hamdy
Nuffield Professor of Surgery, University of Oxford
Verified email at nds.ox.ac.uk
Title
Cited by
Cited by
Year
10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer
FC Hamdy, JL Donovan, JA Lane, M Mason, C Metcalfe, P Holding, ...
New England Journal of Medicine 375 (15), 1415-1424, 2016
28922016
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
1641*2020
Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer
JL Donovan, FC Hamdy, JA Lane, M Mason, C Metcalfe, E Walsh, ...
New England Journal of Medicine 375 (15), 1425-1437, 2016
13142016
Multiple newly identified loci associated with prostate cancer susceptibility
RA Eeles, Z Kote-Jarai, GG Giles, AAA Olama, M Guy, SK Jugurnauth, ...
Nature genetics 40 (3), 316-321, 2008
10062008
Changes in circulating microRNA levels associated with prostate cancer
RJ Bryant, T Pawlowski, JWF Catto, G Marsden, RL Vessella, B Rhees, ...
British journal of cancer 106 (4), 768-774, 2012
8282012
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
FR Schumacher, AA Al Olama, SI Berndt, S Benlloch, M Ahmed, ...
Nature genetics 50 (7), 928-936, 2018
7602018
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
RA Eeles, AAA Olama, S Benlloch, EJ Saunders, DA Leongamornlert, ...
Nature genetics 45 (4), 385-391, 2013
6632013
Quality improvement report Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment …
J Donovan, P Little, N Mills, M Smith, L Brindle, A Jacoby, T Peters, ...
Bmj 325 (7367), 766-770, 2002
647*2002
Prevention and early detection of prostate cancer
J Cuzick, MA Thorat, G Andriole, OW Brawley, PH Brown, Z Culig, ...
The lancet oncology 15 (11), e484-e492, 2014
5872014
Comparison of phytotherapy (Permixon®) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients
JC Carraro, JP Raynaud, G Koch, GD Chisholm, F Di Silverio, P Teillac, ...
The Prostate 29 (4), 231-240, 1996
5571996
MicroRNA in prostate, bladder, and kidney cancer: a systematic review
JWF Catto, A Alcaraz, AS Bjartell, RDV White, CP Evans, S Fussel, ...
European urology 59 (5), 671-681, 2011
5532011
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer
AA Al Olama, Z Kote-Jarai, SI Berndt, DV Conti, F Schumacher, Y Han, ...
Nature genetics 46 (10), 1103-1109, 2014
5202014
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study
RA Eeles, Z Kote-Jarai, AA Al Olama, GG Giles, M Guy, G Severi, K Muir, ...
Nature genetics 41 (10), 1116-1121, 2009
4852009
High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer
C van den Hoogen, G van der Horst, H Cheung, JT Buijs, JM Lippitt, ...
Cancer research 70 (12), 5163-5173, 2010
4432010
Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: the CAP randomized clinical trial
RM Martin, JL Donovan, EL Turner, C Metcalfe, GJ Young, EI Walsh, ...
Jama 319 (9), 883-895, 2018
4352018
Distinct microRNA alterations characterize high-and low-grade bladder cancer
JWF Catto, S Miah, HC Owen, H Bryant, K Myers, E Dudziec, S Larré, ...
Cancer research 69 (21), 8472-8481, 2009
3992009
Multiple loci with different cancer specificities within the 8q24 gene desert
M Ghoussaini, H Song, T Koessler, AA Al Olama, Z Kote-Jarai, KE Driver, ...
JNCI: Journal of the National Cancer Institute 100 (13), 962-966, 2008
3962008
Mre11-dependent degradation of stalled DNA replication forks is prevented by BRCA2 and PARP1
S Ying, FC Hamdy, T Helleday
Cancer research 72 (11), 2814-2821, 2012
3712012
Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells
I Holen, PI Croucher, FC Hamdy, CL Eaton
Cancer research 62 (6), 1619-1623, 2002
3672002
Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2–10 ng/ml: systematic review and meta-analysis
AW Roddam, MJ Duffy, FC Hamdy, AM Ward, J Patnick, CP Price, ...
European urology 48 (3), 386-399, 2005
3622005
The system can't perform the operation now. Try again later.
Articles 1–20